As of Jun 23
| +0.14 / +0.85%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.50, with a high estimate of 21.00 and a low estimate of 16.50. The median estimate represents a +11.71% increase from the last price of 16.56.
The current consensus among 6 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.